Hantavirus Pulmonary syndrome (HPS)
The Hantaviruses are a group of rodent-borne lung diseases and viruses .The Hantaviruses found in Europe and Asia cause a form of kidney disease called hemorrhagic fever with renal syndrome (HFRS).Hantaviruses infect people when they are inhaled. If the virus reaches your lungs, it can infect the cells of tiny blood vessels in the lungs, causing them to become perforated. The perforated blood vessels allow fluid to fill the lungs and hence it decreases the breathe flow.
Related Conference of Hantavirus Pulmonary syndrome (HPS)
October 24-25, 2024
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Paris, France
Hantavirus Pulmonary syndrome (HPS) Conference Speakers
Recommended Sessions
- Abnormalities in breathing regulation
- Betterment of Lung Abscess
- Cardio Pulmonary Disorders
- CO-Morbidities in COPD
- COPD chronic obstructive pulmonary disease
- COPD Exacerbations
- Effect of Thoracic tumors on Lungs
- Hantavirus Pulmonary syndrome (HPS)
- Idiopathic Pulmonary Fibrosis
- Impact of COVID-19 on Lungs
- Interstitial Lung Disease
- Knowledge on Chronic bronchitis and Pulmonary Hypertension
- Lung cancer diagnosis & treatment
- Lung Transplantation
- Mediators of Lung damage and Dysfunction in Tuberculosis
- Occupational & Environmental lung Disease
- Occurrence of Pneumonia in Lungs
- Prevention and Control of Respiratory Diseases
- Pulmonary, Critical care and Sleep
- Relationship between Pancreatitis and Lung diseases
Related Journals
Are you interested in
- Advancements in Pulmonary Diagnostics - Respiratory 2024 (France)
- Asthma - Tuberculosis-2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - Respiratory 2024 (France)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic Obstructive Pulmonary Disease - Respiratory 2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- COVID-19 and Asthma - Respiratory 2024 (France)
- COVID-19 and Respiratory System - Respiratory 2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Idiopathic Pulmonary Fibrosis - Respiratory 2024 (France)
- Interstitial Lung Disease - Respiratory 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung Cancer - Respiratory 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - Respiratory 2024 (France)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Obstructive Sleep Apnea - Respiratory 2024 (France)
- Occupational Lung Diseases - Respiratory 2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pneumonia - Respiratory 2024 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - Respiratory 2024 (France)
- Pulmonary Rehabilitation - Respiratory 2024 (France)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tuberculosis - Respiratory 2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)